Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Uptake of Methylaminolevulinat With Fractional Ablative Laser Technique

NCT01756313 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.

NCT NCT01756313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01756313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Uptake of Methylaminolevulinat With Fractional Ablative Laser Technique
Lead sponsor
Bispebjerg Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2012
Completion date
August 31, 2012
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ablative fractional laser, photodynamic therapy